Literature DB >> 19021013

Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis.

Shinji Morimoto1, Yoshiaki Tokano, Souichiro Nakano, Takashi Watanabe, Yoshihiro Tamayama, Akiko Mitsuo, Jun Suzuki, Hiroshi Kaneko, Iwao Sekigawa, Yoshinari Takasaki.   

Abstract

Proliferative lupus nephritis (PLN) is the common, severe, and important form of lupus nephritis. Recent report showed that T cells producing Interferon (IFN)gamma (Th1 cells) increased in patients with World Health Organization class IV. However, the relation between the increase of Th1 cells and the pathogenesis has been made unclear. The aim of this study was to examine the chemoattractant mechanism of Th1-producing cells and whether in vitro IFNgamma secretion from Th1-producing cells in PLN. The Th1:Th2 ratio in peripheral blood was measured by flow cytometry. The serum levels of IL-2, IFNgamma, IL-13, monocyte chemoattractant protein-1 (MCP-1) and IP-10 were determined by using enzyme-linked immunosorbent assay. In in vitro IFNgamma production assay, CD4(+)T cells co-cultured with IL-12 and/or IL-18. Th1:Th2 ratio in PLN was high and not correlated with the serum Th1 cytokine level. This Th1-producing cell tended to go toward the inflammatory lesion by low CD62L expression and chemokines. The level of MCP-1 and IP-10 in patients with PLN significantly increased. Lastly, in vitro IFNgamma production assay, patients with PLN CD4(+)T cells produced IFNgamma by the addition of IL-12 and IL-18, while CD4(+)T cells in normal controls did not produce. These findings suggest that combination of Th1 inducers and chemokine inhibition might be powerful threrapeutic approach in PLN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19021013     DOI: 10.1080/08916930802438790

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

1.  Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.

Authors:  Jeng-Ting Tsao; Song-Chou Hsieh; Bor-Luen Chiang; Chia-Li Yu; Shih-Chang Lin
Journal:  Clin Exp Med       Date:  2011-11-05       Impact factor: 3.984

2.  Estrogen receptor-alpha mediates Toll-like receptor-2 agonist-induced monocyte chemoattractant protein-1 production in mesangial cells.

Authors:  Subhajit Dasgupta; Jackie Eudaly
Journal:  Results Immunol       Date:  2012-11-10

3.  Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.

Authors:  Pongpratch Puapatanakul; Sonchai Chansritrakul; Paweena Susantitaphong; Thornthun Ueaphongsukkit; Somchai Eiam-Ong; Kearkiat Praditpornsilpa; Wonngarm Kittanamongkolchai; Yingyos Avihingsanon
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

Review 4.  Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications.

Authors:  Jicui Li; Manyu Luo; Bing Li; Yan Lou; Yuexin Zhu; Xue Bai; Baichao Sun; Xuehong Lu; Ping Luo
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 5.  Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases.

Authors:  Jie Gao; Lingling Wu; Siyang Wang; Xiangmei Chen
Journal:  Mediators Inflamm       Date:  2020-02-05       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.